Does the U.S. import oxazepam from India?
The question is whether oxazepam shipments are sourced from India to the U.S. The provided information doesn’t include any supply-chain, import/export, or manufacturer-distribution details confirming that the U.S. receives oxazepam from India.
How can you check if oxazepam imports come from India?
To verify the country of origin for oxazepam entering the U.S., you typically need trade and customs records or regulatory drug-manufacturing sourcing data. Useful places to look include:
- U.S. customs/import datasets (to see shipment “country of origin” for the product)
- FDA and DEA-linked drug listing/registration information for manufacturers and distributors
- Company supply-chain disclosures (rare for small-molecule, generic drugs, but sometimes available in public filings)
Could India be a supplier even if it’s not the only source?
Yes. Even if India supplies some oxazepam, the U.S. could also source from other countries depending on who manufactures the product and which suppliers have U.S. distribution contracts. Without specific import records, you can’t confirm India’s share or whether it is a primary source.
What do you want to verify exactly?
If you tell me one of the following, I can narrow the answer to the right kind of evidence:
- Are you asking about oxazepam tablets/capsules sold in the U.S.?
- Or about bulk API (active pharmaceutical ingredient) used to make oxazepam in the U.S.?
- Do you mean “imported into the U.S.” or “controlled/produced for the U.S. market” (which can differ)?
If you can share the brand name, dosage form, or whether you mean API vs finished product, I can guide you on the most direct way to check the origin.